Effect of Curcumin-Associated and Lipid Ligand-Functionalized Nanoliposomes on Aggregation of the Alzheimer's Aβ Peptide

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

Stewart, J. C. M. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90269-9 · Cited by 1,786 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

Stability of curcumin in buffer solutions and characterization of its degradation products

Wang, Y., Pan, M., Cheng, A., Lin, L., Ho, Y., Hsieh, C., & Lin, J. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,709 · see citing works

Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254 · see citing works

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, K. I., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205 · see citing works

Alzheimer's disease: strategies for disease modification

Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,060 · see citing works

The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform

Hong, S., Leroueil, P. R., Majoros, I., Orr, B. G., Baker, J. R., & Holl, M. M. B. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 585 · see citing works

Studies on curcumin and curcuminoids

T√∏nnesen, H. H., & Karlsen, J. R. (1985) · European Food Research and Technology · doi:10.1007/bf01027775 · Cited by 514 · see citing works

Interaction of Cationic Antimicrobial Peptides with Model Membranes

Zhang, L., Rozek, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104925200 · Cited by 412 · see citing works

Survival Following a Diagnosis of Alzheimer Disease

Brookmeyer, R., Corrada, M. M., Curriero, F. C., & Kawas, C. H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1764 · Cited by 408 · see citing works

Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid

Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100252200 · Cited by 406 · see citing works

Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display

Montet, X., Funovics, M. A., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388 · see citing works

Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides

McLaurin, J., & Chakrabartty, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26482 · Cited by 333 · see citing works

Effects of Naturally Occurring Compounds on Fibril Formation and Oxidative Stress of β-Amyloid

Kim, H., Park, B., Lee, K., Choi, C. Y., Jang, S. S., Kim, Y., & Lee, S. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf051985c · Cited by 297 · see citing works

Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1–42) insult

Kim, D. S. H. L., Park, S., & Kim, J.-Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01677-9 · Cited by 262 · see citing works

Pharmaceutical manufacturing handbook : production and processes

Gad, S. C. (2008) · Wiley-Interscience eBooks · Cited by 234 · see citing works

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide

Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., Ferla, B. L., Salmona, M., Nicotra, F., Gobbi, M., & Antimisiaris, S. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.027 · Cited by 231 · see citing works

Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition

Bernabé‐Pineda, M., Ramı́rez-Silva, M. T., Romero-Romo, M., Vergara, E. G., & Rojas-Hernándéz, A. (2003) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/s1386-1425(03)00342-1 · Cited by 228 · see citing works

Physicochemical interactions of amyloid β-peptide with lipid bilayers

Matsuzaki, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.009 · Cited by 215 · see citing works

Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide

Gobbi, M., Re, F., Canovi, M., Beeg, M., Gregori, M., Sesana, S., Sonnino, S., Brogioli, D., Musicanti, C., Gasco, P., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.044 · Cited by 211 · see citing works

Binding Affinity and Kinetic Analysis of Targeted Small Molecule-Modified Nanoparticles

Tassa, C., Duffner, J. L., Lewis, T. A., Weissleder, R., Schreiber, S. L., Koehler, A. N., & Shaw, S. Y. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900438a · Cited by 202 · see citing works

Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Mann, D. M. A., Iwatsubo, T., Ihara, Y., Cairns, N. J., Lantos, P. L., Bogdanović, N., Lannfelt, L., Winblad, B. G., Maat–Schieman, M. L. C., & Rossor, M. N. (1996) · Europe PMC (PubMed Central) · Cited by 184 · see citing works

Role of gangliosides in Alzheimer’s disease

Yanagisawa, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.018 · Cited by 178 · see citing works

Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurc™) in the Neuronal Cell Culture and Animal Model: Implications for Alzheimer's disease

Ray, B., Bisht, S., Maitra, A., Maitra, A., & Lahiri, D. K. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101374 · Cited by 177 · see citing works

Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

Muhs, A., Hickman, D. T., Pihlgren, M., Chuard, N., Giriens, V., Meerschman, C., der Auwera, I. V., LEUVEN, F. V., Sugawara, M., Weingertner, M.-C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703137104 · Cited by 176 · see citing works

Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of β-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer’s Disease

Taylor, M., Moore, S., Mayes, J., Parkin, E. T., Beeg, M., Canovi, M., Gobbi, M., Mann, D. M. A., & Allsop, D. (2010) · Biochemistry · doi:10.1021/bi100144m · Cited by 162 · see citing works

Targeted Liposomes: Convenient Coupling of Ligands to Preformed Vesicles Using “Click Chemistry”

Hassane, F. S., Frisch, B., & Schuber, F. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050308l · Cited by 153 · see citing works

Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease

Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148 · see citing works

ApoE3 Mediated Poly(butyl) Cyanoacrylate Nanoparticles Containing Curcumin: Study of Enhanced Activity of Curcumin against Beta Amyloid Induced Cytotoxicity Using In Vitro Cell Culture Model

Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900306x · Cited by 147 · see citing works

Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease

Re, F., Airoldi, C., Zona, C., Masserini, M., Ferla, B. L., Quattrocchi, N., & Nicotra, F. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791959729 · Cited by 139 · see citing works

Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition

Kokkona, M., Kallinteri, P., Fatouros, D. G., & Antimisiaris, S. G. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00064-0 · Cited by 133 · see citing works

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation

Thomas, T., Nadackal, T. G., & Thomas, K. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00024 · Cited by 127 · see citing works

Interaction of Amyloid Beta-Protein with Anionic Phospholipids: Possible Involvement of Lys28 and C-Terminus Aliphatic Amino Acids

Chauhan, A., Ray, I., & Chauhan, V. P. S. (2000) · Neurochemical Research · doi:10.1023/a:1007509608440 · Cited by 117 · see citing works

γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio

Yin, Y. I., Bassit, B., Zhu, L., Yang, X., Wang, C., & Li, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704601200 · Cited by 116 · see citing works

Human Glutathione S-Transferase-Mediated Glutathione Conjugation of Curcumin and Efflux of These Conjugates in Caco-2 Cells

Usta, M., Wortelboer, H. M., Vervoort, J. J. M., Boersma, M. G., Rietjens, I. M. C. M., van BLADEREN, P. J., & Cnubben, N. H. P. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7002245 · Cited by 57 · see citing works

Macromolecular Crowding at Membrane Interfaces: Adsorption and Alignment of Membrane Peptides

Aisenbrey, C., Bechinger, B., & Gröbner, G. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.10.053 · Cited by 54 · see citing works

Controlling Amyloid‐β Peptide(1–42) Oligomerization and Toxicity by Fluorinated Nanoparticles

Saraiva, A. M., Cardoso, I., Pereira, M. D. C., Coelho, M. A. N., Saraiva, M. J., Möhwald, H., & Brezesinski, G. (2010) · ChemBioChem · doi:10.1002/cbic.201000237 · Cited by 41 · see citing works

Liposomes and Drug Delivery

Antimisiaris, S. G., Kallinteri, P., & Fatouros, D. G. (2007) · doi:10.1002/9780470259818.ch13 · Cited by 38 · see citing works

Overcoming synthetic Aβ peptide aging: a new approach to an age-old problem

Manzoni, C., Colombo, L., Messa, M., Cagnotto, A., Cantú, L., Favero, E. D., & Salmona, M. (2009) · Amyloid · doi:10.1080/13506120902879848 · Cited by 37 · see citing works

Randomization of Amyloid‐β‐Peptide(1‐42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity

Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900448 · Cited by 35 · see citing works

Potential Protection of Curcumin against Hypoxia-induced Decreases in Beta-III Tubulin Content in Rat Prefrontal Cortical Neurons

Shen, Y., & Yu, L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9720-y · Cited by 30 · see citing works

Role of Biochemical Alzheimer's Disease Biomarkers as End Points in Clinical Trials

Siemers, E., Demattos, R. B., May, P. C., & Dean, R. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.85 · Cited by 23 · see citing works

Liposomes and Drug Delivery

Antimisiaris, S. G., Kallinteri, P., & Fatouros, D. G. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse352 · Cited by 21 · see citing works

Curcumin—From Molecule to Biological Function

Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107724 · Cited by 908 · see citing works

Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century

Lee, W., Loo, C., Bebawy, M., Luk, F., Mason, R. S., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 539 · see citing works

Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease

Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 399 · see citing works

Therapeutic Applications of Curcumin Nanoformulations

Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 397 · see citing works

Protective effect of curcumin against heavy metals-induced liver damage

García‐Niño, W. R., & Pedraza‐Chaverrí, J. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.04.016 · Cited by 383 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Multifunctional Nanoliposomes with Curcumin-Lipid Derivative and Brain Targeting Functionality with Potential Applications for Alzheimer Disease

Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263 · see citing works

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

Pinheiro, R. G. R., Coutinho, A. J., Pinheiro, M., & Neves, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111654 · Cited by 251 · see citing works

Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta

Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219 · see citing works

Nanotechnology—novel therapeutics for CNS disorders

Srikanth, M., & Kessler, J. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.76 · Cited by 198 · see citing works

Liposome delivery systems for the treatment of Alzheimer’s disease

Ross, C., Taylor, M., Fullwood, N., & Allsop, D. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s183117 · Cited by 198 · see citing works

Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

Salehi, B., Călina, D. C., Docea, A. O., Koirala, N., Aryal, S., Lombardo, D., Pasqua, L., Taheri, Y., Castillo, C. M. S., Martorell, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020430 · Cited by 197 · see citing works

Curcumin and neurodegenerative diseases: a perspective

Darvesh, A. S., Carroll, R. T., Bishayee, A., Novotny, N. A., Geldenhuys, W. J., & der Schyf, C. J. V. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.693479 · Cited by 189 · see citing works

Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders

Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 181 · see citing works

Nanotechnology for neurodegenerative disorders

Re, F., Gregori, M., & Masserini, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.015 · Cited by 174 · see citing works

Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

Gao, H., Pang, Z., & Jiang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1122-4 · Cited by 164 · see citing works

Inhibition of Amyloid Fibril Growth and Dissolution of Amyloid Fibrils by Curcumin–Gold Nanoparticles

Palmal, S., Maity, A. R., Singh, B. K., Basu, S., Jana, N. R., & Jana, N. R. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201400079 · Cited by 155 · see citing works

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases

Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112999 · Cited by 155 · see citing works

Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of Alzheimer disease

Bana, L., Minniti, S., Salvati, E., Sesana, S., Zambelli, V., Cagnotto, A., Orlando, A., Cazzaniga, E., Zwart, R., Scheper, W., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.001 · Cited by 151 · see citing works

Curcumin-conjugated Nanoliposomes with High Affinity for Aβ Deposits: Possible Applications to Alzheimer Disease

Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149 · see citing works

Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect

Ansari, N., & Khodagholi, F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040005 · Cited by 131 · see citing works

Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview

Bilal, M., Barani, M., Sabir, F., Rahdar, A., & Kyzas, G. Z. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100251 · Cited by 126 · see citing works

Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review

Laurindo, L. F., de Carvalho, G. M., Zanuso, B. D. O., Figueira, M. E., Direito, R., Goulart, R. D. Á., Buglio, D. S., & Barbalho, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010229 · Cited by 128 · see citing works

Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?

Serafini, M. M., Catanzaro, M., Rosini, M., Racchi, M., & Lanni, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.004 · Cited by 119 · see citing works

Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108 · see citing works

Advances in developing therapeutic strategies for Alzheimer's disease

Nguyen, T. T., Nguyen, T. T. D., Nguyen, T. K. O., Vo, T. K., & Giau, V. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111623 · Cited by 107 · see citing works

Potential protective roles of curcumin against cadmium-induced toxicity and oxidative stress

Park, J. H., Lee, B. M., & Kim, H. S. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1860842 · Cited by 106 · see citing works

Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors

Squillaro, T., Cimini, A., Peluso, G., Giordano, A., & Melone, M. A. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.016 · Cited by 102 · see citing works

Nanomaterials and neurodegeneration

Migliore, L., Uboldi, C., Bucchianico, S. D., & Coppedè, F. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21931 · Cited by 101 · see citing works

Nanomedicine for the Treatment of Alzheimer’s Disease

Gregori, M., Masserini, M., & Mancini, S. (2015) · Nanomedicine · doi:10.2217/nnm.14.206 · Cited by 99 · see citing works

Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease

Fernandes, M. S., Lopes, I., Magalhães, L., Sárria, M. P., Machado, R., Sousa, J. C., Botelho, C., Teixeira, J. A., & Gomes, A. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.018 · Cited by 95 · see citing works

Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons

Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 101 · see citing works

A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease

Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C. L., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054769 · Cited by 93 · see citing works

Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy

Abdel-Hafez, S. M., Hathout, R. M., & Sammour, O. A. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.051 · Cited by 90 · see citing works

Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases

Babazadeh, A., Vahed, F. M., & Jafari, S. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.015 · Cited by 89 · see citing works

Mitochondrial therapeutic interventions in Alzheimer’s disease

Giau, V. V., An, S. S. A., & Hulme, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 87 · see citing works

Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review

Mandal, M., Jaiswal, P., & Mishra, A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22478 · Cited by 86 · see citing works

Nanotechnology for neurodegenerative disorders

Re, F., Gregori, M., & Masserini, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.007 · Cited by 84 · see citing works

A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease

Mittal, P., Dhankhar, S., Chauhan, S., Garg, N., Bhattacharya, T., Ali, M., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M. M., Ahmad, W., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070908 · Cited by 82 · see citing works

Cadmium‐induced toxicity is rescued by curcumin: A review

Mohajeri, M., Rezaee, M., & Sahebkar, A. (2017) · BioFactors · doi:10.1002/biof.1376 · Cited by 80 · see citing works

Inhibition of Amyloid Fibril Growth by Nanoparticle Coated with Histidine-Based Polymer

Palmal, S., Jana, N., & Jana, N. (2014) · The Journal of Physical Chemistry C · doi:10.1021/jp505613g · Cited by 71 · see citing works

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works

Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point

Bose, T., Latawiec, D., Mondal, P. P., & Mandal, S. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2527-7 · Cited by 71 · see citing works

Dual-functional nanoparticles for precise drug delivery to Alzheimer’s disease lesions: Targeting mechanisms, pharmacodynamics and safety

Zheng, X., Zhang, C., Guo, Q., Xu, W., Shao, X., Liu, Q., & Zhang, Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.033 · Cited by 71 · see citing works

Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75 · see citing works

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 66 · see citing works

Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation

Shao, X., Yan, C., Wang, C., Wang, C., Cao, Y. Q., Zhou, Y., Guan, P., Hu, X., Zhu, W., & Ding, S. (2022) · Nanoscale Advances · doi:10.1039/d2na00625a · Cited by 63 · see citing works

Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide

Gregori, M., Taylor, M., Salvati, E., Re, F., Mancini, S., Balducci, C., Forloni, G., Zambelli, V., Sesana, S., Michael, M., et al. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.006 · Cited by 62 · see citing works

Peptide-Functionalized Nanomedicine: Advancements in Drug Delivery, Diagnostics, and Biomedical Applications

Omidian, H., Cubeddu, L. X., & Wilson, R. L. (2025) · Molecules · doi:10.3390/molecules30071572 · Cited by 60 · see citing works

Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS

Rabanel, J., Faivre, J., Paka, G. D., Ramassamy, C., Hildgen, P., & Banquy, X. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.004 · Cited by 58 · see citing works

Rescuing apoptotic neurons in Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin

Kuo, Y.-C., & Lin, C.-C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79528 · Cited by 56 · see citing works

Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine

Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 56 · see citing works

Anti-Aβ-MAb and dually decorated nanoliposomes: Effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells

Markoutsa, E., Παπαδιά, Κ., Clemente, C., Flores, O., & Antimisiaris, S. G. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.006 · Cited by 56 · see citing works

Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice

Παπαδιά, Κ., Giannou, A. D., Markoutsa, E., Bigot, C., Vanhoute, G., Mourtas, S., der Linded, A. V., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.010 · Cited by 56 · see citing works

Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases

Smith, J. A., Leonardi, T., Huang, B., Iraci, N., Vega, B., & Pluchino, S. (2014) · Biogerontology · doi:10.1007/s10522-014-9510-7 · Cited by 53 · see citing works

Advances in nanotechnology for diagnosis and treatment of tuberculosis

Banyal, S., Malik, P., Tuli, H. S., & Mukherjee, T. K. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835eff08 · Cited by 53 · see citing works

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy

Tosi, G., Pederzoli, F., Belletti, D., Vandelli, M. A., Forni, F., Duskey, J. T., & Ruozi, B. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.001 · Cited by 53 · see citing works

Application of Nanodiagnostics and Nanotherapy to CNS Diseases

Zhang, W., Wang, W., Yu, D. X., Xiao, Z., & He, Z. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0163 · Cited by 50 · see citing works

Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders

Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 49 · see citing works

Impact of nanoparticles on amyloid β-induced Alzheimer’s disease, tuberculosis, leprosy and cancer: a systematic review

Chakraborty, A., Mohapatra, S. S., Barik, S., Roy, I., Gupta, B., & Biswas, A. (2023) · Bioscience Reports · doi:10.1042/bsr20220324 · Cited by 45 · see citing works

Liposomes containing cyclodextrins or meglumine to solubilize and improve the bioavailability of poorly soluble drugs

Aloisio, C., Antimisiaris, S. G., & Longhi, M. R. (2016) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2016.12.035 · Cited by 45 · see citing works

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects

Chopra, H., Bibi, S., Singh, I., Kamal, M. A., Islam, F., Alhumaydhi, F. A., Emran, T. B., & Cavalu, S. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879114 · Cited by 47 · see citing works

Nanoneuromedicine for management of neurodegenerative disorder

Dwivedi, N., Shah, J., Mishra, V. K., Tambuwala, M. M., & Kesharwani, P. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.021 · Cited by 44 · see citing works

Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease

Albadrani, H. M., Chauhan, P., Ashique, S., Babu, M. A., Iqbal, D., Almutary, A. G., Abomughaid, M. M., Kamal, M., Paiva‐Santos, A. C., Alsaweed, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116376 · Cited by 44 · see citing works

Activation of anti-oxidant of curcumin pyrazole derivatives through preservation of mitochondria function and Nrf2 signaling pathway

Liao, L., Shi, J., Jiang, C., Zhang, L., Feng, L., Liu, J., & Zhang, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.026 · Cited by 44 · see citing works

Preparation and characterization of curcumin‐loaded polymeric nanomicelles to interference with amyloidogenesis through glycation method

Mirzaie, Z., Ansari, M., Kordestani, S. S., Habibi-Rezaei, M., & Mozafari, M. (2019) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1751 · Cited by 43 · see citing works

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

Huang, Y., Chang, Y. K., Liu, L., & Wang, J. (2021) · Molecules · doi:10.3390/molecules26144301 · Cited by 42 · see citing works

Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases

Bandiwadekar, A., Jose, J., Khayatkashani, M., Habtemariam, S., Kashani, H. R. K., & Nabavi, S. M. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01922-7 · Cited by 42 · see citing works

Multifunctional LUV Liposomes Decorated for BBB and Amyloid Targeting. A. In Vitro Proof-of-Concept

Papadia, K., Markoutsa, E., Mourtas, S., Giannou, A. D., La Ferla, B., Nicotra, F., Salmona, M., Klepetsanis, P., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.02.019 · Cited by 40 · see citing works

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

Garbayo, E., de Mendoza, A. E., & Blanco‐Prieto, M. J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140815124246 · Cited by 37 · see citing works

Delivery systems for theranostics in neurodegenerative diseases

Li, Y., Liu, R., Ji, W., Li, Y., Liu, L., & Zhang, X. (2018) · Nano Research · doi:10.1007/s12274-018-2067-z · Cited by 35 · see citing works

Nanotherapeutic strategies for the treatment of neurodegenerative diseases

Huang, M., Gu, X. Q., & Gao, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00013-5 · Cited by 34 · see citing works

Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.

Far, B., Safaei, M., Pourmolaei, A., Adibamini, S., Shirdel, S., Shirdel, S., Emadi, R., & Kaushik, A. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00112 · Cited by 30 · see citing works

Alzheimer’s disease: review of current nanotechnological therapeutic strategies

Baranowska‐Wójcik, E., & Szwajgier, D. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1719069 · Cited by 33 · see citing works

Nanotechnology in the diagnostic and therapy for Alzheimer's disease

Panghal, A., & Flora, S. J. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130559 · Cited by 31 · see citing works

Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases

Wang, Z., Sreenivasmurthy, S. G., Song, J., Liu, J.-Y., & Li, M. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.001 · Cited by 31 · see citing works

Curcumin – vom Molekül zur biologischen Wirkung

Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. H. (2012) · Angewandte Chemie · doi:10.1002/ange.201107724 · Cited by 30 · see citing works

Nanomedicine applications in women's health: state of the art

Lloyd-Parry, O., Downing, C., Aleisaei, E., Jones, C., & Coward, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s97572 · Cited by 31 · see citing works

Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages

Re, F., Antonina, O., Sesana, Rivolta, I., Panariti, Brambilla, Nicolas, J., Couvreur, Andrieux, K., Masserini, et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40297 · Cited by 29 · see citing works

Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis

Pillai, S. C., Borah, A., Jacob, E. M., & Kumar, D. S. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1892241 · Cited by 29 · see citing works

Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide

Airoldi, C., Mourtas, S., Cardona, F., Zona, C., Sironi, E., D’Orazio, G., Markoutsa, E., Nicotra, F., Antimisiaris, S. G., & Ferla, B. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.085 · Cited by 28 · see citing works

“Squalenoylcurcumin” Nanoassemblies as Water‐Dispersible Drug Candidates with Antileishmanial Activity

Cheikh‐Ali, Z., Caron, J., Cojean, S., Bories, C., Couvreur, P., Loiseau, P. M., Desmaële, D., Poupon, E., & Champy, P. (2014) · ChemMedChem · doi:10.1002/cmdc.201402449 · Cited by 27 · see citing works

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease

Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C. L., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., et al. (2013) · PLoS ONE · doi:10.1371/annotation/57e0a947-8600-4658-b04c-cf7a45c8bd8d · Cited by 27 · see citing works

Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases

Khot, K. B., Gopan, G., Bandiwadekar, A., & Jose, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101806 · Cited by 25 · see citing works

Modern aspects of the use of natural polyphenols in tumor prevention and therapy

Суфианова, Г. З., Фанилевич, Г. И., Beylerli, O., Wu, J., Shumadalova, A. V., Sufianov, A. A., Chen, X., & Zhao, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1011435 · Cited by 24 · see citing works

Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants

Prasad, K. N., & Bondy, S. C. (2014) · Current Aging Science · doi:10.2174/1874609807666140804115633 · Cited by 24 · see citing works

Development and application of nano-flavor-drug carriers in neurodegenerative diseases

Ji, W., Xiao, Z.-B., Liu, G., & Zhang, X. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.06.024 · Cited by 22 · see citing works

Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity

Kuo, Y., & Liu, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.003 · Cited by 21 · see citing works

Nanopharmaceuticals: Innovative theranostics for the neurological disorders

Hassanzadeh, P. (2014) · Biomedical Reviews · doi:10.14748/bmr.v25.1043 · Cited by 21 · see citing works

Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease

Robinson, M. J., Lee, B. Y., & Leonenko, Z. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.332 · Cited by 24 · see citing works

A New Perspective on the Treatment of Alzheimer’s Disease and Sleep Deprivation‐Related Consequences: Can Curcumin Help?

Akkol, E. K., Bardakçı, H., Yücel, Ç., Karatoprak, G. Ş., Karpuz, B., & Khan, H. Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6168199 · Cited by 20 · see citing works

Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches

Kaluza, M., Ksiazek-Winiarek, D. J., Szpakowski, P., Czpakowska, J., Fijalkowska, J., & Glabinski, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136477 · Cited by 24 · see citing works

Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19 · see citing works

Polyphenols and Their Biogenic Nano‐Formulations Targeting BACE1 as Anti‐Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease

Elawad, M. A., Ayaz, M., Mosa, O. F., Usman, A., Hamdoon, A. A. E., Almawash, S., Salim, L. H. M., Ahmed, A., & Elkhalifa, M. E. M. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400525 · Cited by 20 · see citing works

Molecular dynamic studies of amyloid-beta interactions with curcumin and Cu2+ ions

Kozmon, S., & Tvaroška, I. (2015) · Chemical Papers · doi:10.1515/chempap-2015-0134 · Cited by 18 · see citing works

Liposome nanoparticle conjugation and cell penetrating peptide sequences ( CPPs ) enhance the cellular delivery of the tau aggregation inhibitor RI ‐ AG03

Reich, N., Allsop, D., Parkin, E. T., & Dawson, N. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18477 · Cited by 14 · see citing works

Liposomes Decorated with 2-(4′-Aminophenyl)benzothiazole Effectively Inhibit Aβ1–42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential

Mourtas, S., Mavroidi, B., Marazioti, A., Kannavou, M., Sagnou, M., Pelecanou, M., & Antimisiaris, S. G. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00811 · Cited by 14 · see citing works

Biomembrane-Derived Nanoparticles in Alzheimer’s Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles

Gao, C., Liu, Y., Zhang, T., Luo, Y., Gao, J., Chu, J., Gong, B., Chen, X., Yin, T., Zhang, J., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436774 · Cited by 14 · see citing works

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy

Ortiz-Islas, E., Montes, P., Rodríguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala‐Tecuapetla, C., Carvajal, K., & Campos‐Peña, V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010128 · Cited by 12 · see citing works

Curcumin Reduces Amyloid Beta Oligomer Interactions with Anionic Membranes

Sallaberry, C. A., Voss, B. J., Stone, W. B., Estrada, F., Bhatia, A., Soto, J. D., Griffin, C. W., & Zanden, C. M. V. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00512 · Cited by 11 · see citing works

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide

Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., Ferla, B. L., Salmona, M., Nicotra, F., Gobbi, M., & Antimisiaris, S. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.027 · Cited by 231 · see citing works

Curcumin-conjugated Nanoliposomes with High Affinity for Aβ Deposits: Possible Applications to Alzheimer Disease

Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149 · see citing works

Multifunctional Nanoliposomes with Curcumin-Lipid Derivative and Brain Targeting Functionality with Potential Applications for Alzheimer Disease

Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263 · see citing works

Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity

Markoutsa, E., Mourtas, S., Bereczki, E., Zona, C., Ferla, B. L., Nicotra, F., Flores, O., Pei, J.-J., & Antimisiaris, S. G. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150605115902 · Cited by 10 · see citing works

Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide

SANCINI, G. A., Gregori, M., Zona, C., Masserini, M., Cambianica, I., & Salvati, E. (2012) · BOA (University of Milano-Bicocca)